Avantis US Small Cap Value ETF vs Cassava Sciences Inc — how do they compare? Avantis US Small Cap Value ETF trades at $127.8, while Cassava Sciences Inc trades at $0.97 (market cap $47.75M). The key difference: Avantis US Small Cap Value ETF is trading nearer its 52-week high, Cassava Sciences Inc nearer its low. Which is the better fit depends on your goals.
| AVUV | FLNA | |
|---|---|---|
Sector | Sector/Thematic | Health |
52-Week High | $128.74 | $4.64 |
52-Week Low | $93.93 | $0.87 |
Market Cap | — | $47.75M |
Enterprise Value | — | -$34.93M |
Signals from Pluang's Aura AI — not financial advice
AVUV trades at $126.88, up 0.36% today, with a bullish technical signal from moving averages and neutral oscillators. Recent news highlights strong small-cap value performance and potential benefits from rate outlook shifts. The ETF focuses on U.S. small-cap value stocks, offering diversification from tech-heavy portfolios.
Outlook remains positive due to small-cap momentum and value factor tailwinds, but risks include higher volatility and sensitivity to interest rates. Analyst sentiment is favorable, emphasizing long-term growth potential in tax-advantaged accounts like Roth IRAs.
No Aura AI signal available yet.
Trailing returns across standard periods
AVUV is an actively managed ETF that targets small-cap value companies in the United States. It uses a systematic, rules-based process to identify firms with low valuations and high profitability, aiming to capture the historical premiums of 'size' and 'value' while filtering for financial quality.
Read more on AVUV →Cassava Sciences Inc is a clinical-stage biotechnology company engaged in developing a scientific approach for the treatment and detection of Alzheimer's disease. Its therapeutic product candidate is called simufilam, and it is a novel treatment for Alzheimer's disease
Read more on FLNA →